June 24, 2014
A hospital action group known as Min-Iren issued a statement on June 20, calling on Novartis Pharma to return “unfair profits” earned from the company’s scandal-plagued blood pressure drug Diovan (valsartan). In the statement, the group, formally the Japan Federation...read more